Back to search
FDAFDA · Food and drugs·Recall number D-0507-2019

Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01

Published February 27, 2019 · Recall initiated: January 31, 2019

Summary

FDA records drug Class II recall D-0507-2019, published February 27, 2019 and initiated January 31, 2019. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 10,656 bottles; Lot: Lot #: C802676, Exp 03/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification results observed for high dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email if DIVALPROEX SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DIVALPROEX SODIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
U.S.A. Nationwide
Lot
Lot #: C802676, Exp 03/20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01 recalled?

Yes. FDA published recall D-0507-2019 on February 27, 2019. Reported hazard: Failed Dissolution Specifications: Out of specification results observed for high dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DIVALPROEX SODIUM.